 WILMETTE, Ill., March 08, 2022 GLOBE NEWSWIRE -- Monopar Therapeutics Inc. Nasdaq: MNPR, a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today announced that Chandler Robinson, MD, Monopars Chief Executive Officer, will present at the 34th Annual Roth Conference and Maxims 2022 Virtual Growth Conference. 